Mirabella Financial Services’s Charles River Laboratories CRL Stock Holding History

Mirabella Financial Services’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-63,924	Closed	-$13.2M	–	231
2024 Q2	$13.2M	Buy	+63,924	New	+$14.5M	0.96%	26
2022 Q1	–	Sell	-30,574	Closed	-$11.5M	–	568
2021 Q4	$11.5M	Buy	30,574 +17,257	+130%	+$6.7M	1.17%	11
2021 Q3	$5.5M	Buy	13,317 +4,986	+60%	+$2.07M	0.72%	39
2021 Q2	$3.08M	Sell	8,331 -20,696	-71%	-$6.91M	0.55%	62
2021 Q1	$8.41M	Buy	29,027 +7,134	+33%	+$1.98M	2.61%	4
2020 Q4	$5.47M	Buy	21,893 +16,272	+289%	+$3.88M	0.68%	59
2020 Q3	$1.27M	Buy	+5,621	New	+$1.17M	0.17%	78

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Mirabella Financial Services's CRL Position: Q3 2024 in Review

Mirabella Financial Services sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 63,924 shares — an estimated $13.2M sold.

Mirabella Financial Services first reported a position in CRL in Q3 2020 and held it in 7 quarters. The position peaked at $13.2M in Q2 2024. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

Mirabella Financial Services reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
Mirabella Financial Services sold 63,924 Charles River Laboratories shares in Q3 2024, an estimated $13.2M.
Mirabella Financial Services first reported a position in Charles River Laboratories in Q3 2020 and held it in 7 quarters.
Mirabella Financial Services's Charles River Laboratories position peaked at $13.2M in Q2 2024.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.